People: Accuray Inc (ARAY.O)
ARAY.O on Nasdaq
5.29USD
23 May 2013
5.29USD
23 May 2013
Price Change (% chg)
$-0.01 (-0.19%)
$-0.01 (-0.19%)
Prev Close
$5.30
$5.30
Open
$5.25
$5.25
Day's High
$5.42
$5.42
Day's Low
$5.24
$5.24
Volume
1,031,949
1,031,949
Avg. Vol
1,056,687
1,056,687
52-wk High
$7.44
$7.44
52-wk Low
$3.76
$3.76
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Louis Lavigne |
64 | 2010 | Independent Chairperson of the Board |
Joshua Levine |
48 | 2012 | President, Chief Executive Officer, Director |
Elizabeth Davila |
58 | 2008 | Independent Vice Chairperson of the Board |
Derek Bertocci |
58 | 2009 | Chief Financial Officer, Senior Vice President |
Kelly Londy |
45 | 2013 | Executive Vice President, Chief Commercial Officer |
Robert Ragusa |
2013 | Executive Vice President - Engineering and Global Operations | |
Darren Milliken |
42 | 2009 | Senior Vice President, General Counsel, Corporate Secretary |
Theresa Dadone |
58 | 2007 | Senior Vice President - Human Resources |
Jack Goldstein |
65 | 2010 | Independent Director |
Richard Pettingill |
64 | 2012 | Independent Director |
Emad Rizk |
2013 | Independent Director | |
Robert Weiss |
66 | 2007 | Independent Director |
Dennis Winger |
65 | 2009 | Independent Director |
Thomas Rathjen |
Vice President, Investor Relations |
Biographies
| Name | Description |
|---|---|
Louis Lavigne |
Mr. Louis J. Lavigne, Jr., is Independent Chairperson of the Board of Accuray Incorporated. Mr. Lavigne has been Managing Director of Lavite, LLC, a management-consulting firm specializing in the areas of corporate finance, accounting and growth strategy and management since 2005. From 1983 to 2005, Mr. Lavigne served in various executive capacities with Genentech, Inc., a healthcare company, namely, Executive Vice President and Chief Financial Officer from 1997 to 2005; Senior Vice President and Chief Financial Officer from 1994 to 1997; Vice President and Chief Financial Officer from 1988 to 1994; Vice President from 1986 to 1988; and Controller from 1983 to 1986. Mr. Lavigne has also served on the boards of directors of Allergan, Inc., a technology-driven, global health care company that provides specialty pharmaceutical products worldwide since 2005 and BMC Software, Inc., an independent systems software vendor that specializes in software solutions that allow companies to manage their information technology infrastructure from a business perspective since 2008, and he previously served on BMC Software's board of directors from 2004 to 2007. Mr. Lavigne also currently serves as a member of the board of directors of SafeNet, Inc., a private information security company. Within the past five years, Mr. Lavigne also served as a director of the following public companies: Arena Pharmaceuticals, Inc., Equinix, Inc. and Kyphon, Inc, as well as private companies Emphasis Search, Inc. and Life Masters Supported Self Care. Mr. Lavigne serves as a board member of Children's Hospital in Oakland, California, as a faculty member of Babson College's Bio-Pharma: Mastering the Business of Science Program, as a Trustee of Babson College (and Babson Global) and of the California Institute of Technology (CalTech) and of the Seven Hills School. Mr. Lavigne holds a B.S. in Finance from Babson College in Babson Park, Massachusetts, and an M.B.A. from Temple University in Philadelphia, Pennsylvania. |
Joshua Levine |
Mr. Joshua H. Levine is President, Chief Executive Officer, Director Accuray Inc. since October 12, 2012. From November 2011 to the time he joined the Company in October 2012, Mr. Levine attended to personal matters. Mr. Levine served from June 2011 to October 2011 as the President and Chief Executive Officer and as a member of the Board of Directors of Immucor Corporation, a diagnostics manufacturer of automated instrumentation and reagents used in transfusion medical procedures. From August 2010 through May 2011, Mr. Levine worked as an independent consultant. Prior thereto, Mr. Levine served in several executive capacities during his 14-year tenure with Mentor Corporation, a medical device/surgical implant manufacturer that was acquired by Johnson & Johnson in early 2009. At Mentor Corporation, post acquisition by Johnson & Johnson, Mr. Levine served as Worldwide President from January 2009 to July 2010 and, prior to acquisition by Johnson & Johnson, as President and Chief Executive Officer and a member of the Board of Directors from June 2004 to January 2009. Mr. Levine holds a B.A. from the University of Arizona. |
Elizabeth Davila |
Ms. Elizabeth H. Davila is Independent Vice Chairperson of the Board of Accuray Incorporated. Ms. Dávila was the former Chairman and Chief Executive Officer of VISX, Incorporated ("VISX"), a manufacturer of laser vision correction systems, which was acquired by Advanced Medical Optics in May 2005. Prior to becoming Chairman and Chief Executive Officer of VISX in 2001, she served as President and Chief Operating Officer of VISX from 1999 to 2001 and as Executive Vice President and Chief Operating Officer from 1995 to 1999. Ms. Dávila currently serves as a member of the board of directors of NuGEN Technologies, Inc., a private company that develops and commercializes rapid, high-sensitivity and high-throughput amplification and labeling systems for genomic analysis, and Afaxys, Inc., a private company that supplies planning providers with pharmaceuticals and supplies. Within the last five years, Ms. Dávila also served on the public company boards of directors of Advanced Medical Optics, Inc. (now Abbott Medical Optics) and Cholestech Corp., medical device companies that were acquired in 2009 and 2007, respectively. Ms. Dávila holds a B.S. in Chemistry from St. Mary's College in Notre Dame, Indiana, an M.S. in Chemistry from the University of Notre Dame in Notre Dame, Indiana, and an M.B.A. from Stanford University in Stanford, California. |
Derek Bertocci |
Mr. Derek A. Bertocci is Chief Financial Officer, Senior Vice President of Accuray Incorporated., since January 1, 2009. From October 2006 through December 2008, Mr. Bertocci served as the Chief Financial Officer of BioForm Medical, Inc., a publicly traded medical aesthetics company, and added the title of corporate secretary in July 2007. From June 2005 to July 2006, he was Chief Financial Officer of Laserscope, a publicly traded provider of lasers and fiber optic devices for urology and aesthetic surgery. From March 2004 to May 2005, Mr. Bertocci served as Chief Financial Officer of VISX Incorporated, a publicly traded provider of systems for laser vision correction surgery. From 1998 to March 2004, Mr. Bertocci served as Vice President and Controller of VISX. Mr. Bertocci earned his Certified Public Accountant certification while working for PricewaterhouseCoopers. Mr. Bertocci holds a B.A. from Stanford University in Stanford, California and an M.B.A. from the University of Southern California, Los Angeles, California. |
Kelly Londy |
Ms. Kelly Londy has been appointed as Executive Vice President, Chief Commercial Officer of Accuray Inc., effective April 16, 2013. She served as Senior Vice President, Chief Commercial Officer of the Company. From August 2009 to September 2011 Ms. Londy served as Vice President and General Manager of Molecular Imaging, at GE Healthcare North America, where she optimized multi-business strategy with a focus on value proposition for improved cost, quality and access to new technologies. From July 2002 to August 2009, she held roles in Marketing, Executive Account Management and as a product specialist in the MR and Women's Health businesses at GE. Prior to that, from July 2002 to August 2009, Ms. Londy served as Vice President and General Manager at Philips Healthcare North America, where she held multiple roles. Londy began her career as a radiographer and manager at the University of Michigan. Ms. Londy holds a degree in Radiologic Technology from Washtenaw College in Ypsilanti, Michigan and a BBA from Cleary University in Ypsilanti, Michigan where she graduated Suma Cum Laude. |
Robert Ragusa |
Mr. Robert Ragusa has been appointed as Executive Vice President - Engineering and Global Operations of Accuray Inc., effective April 16, 2013. He served as Senior Vice President, Global Operations of the Company. |
Darren Milliken |
Mr. Darren J. Milliken is Senior Vice President, General Counsel, Corporate Secretary of Accuray Incorporated., since May 2009. Mr. Milliken first joined the company as Assistant General Counsel in April 2004, and served as the company Interim General Counsel from September 2008 until May 2009. From September 2003 to April 2004, Mr. Milliken served as Senior Corporate & Intellectual Property Counsel at Sanmina-SCI Corporation, a publicly held global electronics manufacturing services company that serves original equipment manufacturers in technology-related industries such as medical devices, communications and computer hardware. From May 2000 to June 2003, Mr. Milliken served in multiple positions at Voyan Technology, a privately-held company that delivers signal processing and equipment control solutions, including Senior Intellectual Property Counsel, Associate/General Counsel and Director of Human Resources. From September 1995 to May 2000, Mr. Milliken was an associate at the law firm of Blakely Sokoloff Taylor & Zafman LLP. Mr. Milliken holds a B.A. in Physics from Washington & Jefferson College in Washington, Pennsylvania and a J.D. from Santa Clara University in Santa Clara, California. |
Theresa Dadone |
Ms. Theresa L. Dadone is Senior Vice President - Human Resources of Accuray Incorporated., since July 20, 2007. From May 2007 to July 2007, Ms. Dadone was attending to personal matters. From February 2003 through April 2007, Ms. Dadone served in various human resources management roles, including Vice President of Human Resources at Hewlett-Packard Company. Prior to that, from January 2001 through February 2003, Ms. Dadone served as Vice President Human Resources for Propel, Inc., a web acceleration company, and as Senior Vice President, Human Resources for Healtheon/WebMD from January 1998 to January 2001. Ms. Dadone holds a B.S. degree in Clinical Psychology from San Jose State University in San Jose, California. |
Jack Goldstein |
Dr. Jack Goldstein, Ph.D., is Independent Director of Accuray Incorporated., since May 25, 2010. Dr. Goldstein has been an independent consultant since 2006 specializing in human medical diagnostics, biopharmaceuticals and medical devices. He served as President and Chief Operating Officer of Chiron Corporation from 2004 until its acquisition by Novartis in 2006, and from 2002 to 2004 he served as President of Chiron's Blood Testing Division. From 2000 to 2002, he was a general partner at Windamere Venture Partners, a private venture capital investment fund. From 1997 to 2001, he served as President and Chief Executive Officer at Applied Imaging Corporation, and from 1999 until 2002, he also served as Chairman of the Board of Applied Imaging. From 1986 to 1997, Dr. Goldstein served in various executive positions at Johnson & Johnson, including President of Ortho Diagnostic Systems and Executive Vice President of Professional Diagnostics. Dr. Goldstein currently serves as Chairman of the Board of Directors of OncoGenex Pharmaceuticals, Inc. In the past five years, Dr. Goldstein has also served on the following public company boards of directors: Immucor, Inc., Illumina, Inc. and Orasure Technologies, Inc. Dr. Goldstein holds a B.A. in biology from Rider University and an M.S. in immunology and a Ph.D. in microbiology from St. John's University. |
Richard Pettingill |
Mr. Richard R. Pettingill is Independent Director of Accuray Incorporated., since May 11, 2012. Mr. Pettingill served as the President and Chief Executive Officer of Allina Hospitals and Clinics, Minnesota's healthcare organization, from 2002 until his retirement in 2009. While in this role, he also served on the board of directors of the Minnesota Hospital Association and the Minnesota Business Partnership. Prior to joining Allina Hospitals and Clinics, Mr. Pettingill served as President and Chief Executive Officer of the California Division of Kaiser Foundation Health Plans and Hospitals, one of the not-for-profit managed healthcare companies in the United States, from 1996 to 2002. Mr. Pettingill currently serves on the boards of directors of MAKO Surgical Corp., a medical devices company, and Tenet Healthcare Corporation, a medical services provider. Mr. Pettingill received a bachelor's degree from San Diego State University and a master's degree in health care administration from San Jose State University. He served as a 2010 Fellow in the Advanced Leadership Initiative program at Harvard University. |
Emad Rizk |
Dr. Emad Rizk, M.D., has been appointed as Independent Director of Accuray Inc., effective March 15, 2013. Since 2003, Dr. Rizk has served as the President of McKesson Health Solutions (“McKesson”), a division of McKesson Corporation. McKesson enables healthcare organizations that manage financial risk to compete by helping payers and providers partner for better healthcare outcomes at lower costs. Prior to joining McKesson, Dr. Rizk served as the lead partner and global director, medical management/pharmacy for Deloitte Consulting from 1994 to 2003. Dr. Rizk currently serves on the board of directors of Disease Management Association of America, a nonprofit organization representing all aspects of the disease management community, and is a past vice-chairman of the National Clinical Advisory Board, a healthcare organization focused on providing insight into the future direction of healthcare, management and delivery of patient care. |
Robert Weiss |
Mr. Robert S. Weiss is Independent Director of Accuray Incorporated., since January 2007. Since November 2007, Mr. Weiss has served as the Chief Executive Officer of The Cooper Companies, Inc. ("Cooper"), a global specialty medical products company. He was also given the title of President of Cooper in March 2008. Mr. Weiss has served in various senior executive management positions with Cooper since 1989. From January 2005 through October 2007, Mr. Weiss served as the Executive Vice President and Chief Operating Officer of Cooper, and from March 2007 to March 2008, he also served as President of CooperVision, Cooper's contact lens subsidiary. Prior to that, he served as Cooper's Chief Financial Officer from September 1989 to January 2005 and held the additional title of Executive Vice President from October 1995 until November 2007. From March 1984 until October 1995 he served at Cooper in various other roles, including Senior Vice President, Vice President and Corporate Controller. Mr. Weiss has also served on the board of directors of Cooper since 1996. Mr. Weiss holds a B.S. in Accounting from the University of Scranton in Scranton, Pennsylvania. |
Dennis Winger |
Mr. Dennis L. Winger is Independent Director of Accuray Incorporated., since September 11, 2009. Mr. Winger most recently served as Senior Vice President and Chief Financial Officer of Applied Biosystems, Inc. from 1997 to 2008. Mr. Winger has also served on the boards of directors of Cephalon, Inc., a drug developer and seller, with activities focusing on central nervous system disorders since 2003; Vertex Pharmaceuticals, a company that discovers, develops and markets small molecule drugs that address viruses, cancer and autoimmune, inflammatory and neurological diseases since 2009; and Nektar Therapeutics, a biopharmaceutical company, since 2009. In the last five years, Mr. Winger also served as a director of Cell Genesys, Inc. and A.P. Pharma Inc. Mr. Winger also serves on the Board of Trustees of Siena College. Mr. Winger holds a B.A. in History from Siena College in Loudonville, New York and an M.B.A. from Columbia University in New York, New York. |
Thomas Rathjen |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Louis Lavigne |
-- |
Joshua Levine |
-- |
Elizabeth Davila |
-- |
Derek Bertocci |
617,875 |
Kelly Londy |
731,865 |
Robert Ragusa |
-- |
Darren Milliken |
430,195 |
Theresa Dadone |
479,103 |
Jack Goldstein |
-- |
Richard Pettingill |
-- |
Emad Rizk |
-- |
Robert Weiss |
-- |
Dennis Winger |
-- |
Thomas Rathjen |
-- |
As Of 29 Jun 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Louis Lavigne |
0 | 0 |
Joshua Levine |
0 | 0 |
Elizabeth Davila |
0 | 0 |
Derek Bertocci |
0 | 0 |
Kelly Londy |
0 | 0 |
Robert Ragusa |
0 | 0 |
Darren Milliken |
9,000 | 42,800 |
Theresa Dadone |
0 | 0 |
Jack Goldstein |
0 | 0 |
Richard Pettingill |
0 | 0 |
Emad Rizk |
0 | 0 |
Robert Weiss |
0 | 0 |
Dennis Winger |
0 | 0 |
Thomas Rathjen |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
LONDY KELLY J |
60,000 | $0.00 |
RAGUSA ROBERT P |
80,000 | $0.00 |
RIZK EMAD T |
17,241 | $0.00 |
RAGUSA ROBERT P |
18,000 | $0.00 |
WINGER DENNIS L |
20,000 | $4.30 |
LEVINE JOSHUA H |
100,000 | $4.38 |
LONDY KELLY J |
100 | $5.26 |
LONDY KELLY J |
27,500 | $0.00 |
LONDY KELLY J |
2,547 | $6.28 |
LAVIGNE LOUIS J JR |
19,108 | $0.00 |
DADONE THERESA L |
791 | $5.24 |
WEISS ROBERT S |
19,108 | $0.00 |
GOLDSTEIN JACK |
19,108 | $0.00 |
BERTOCCI DEREK A |
2,419 | $5.24 |
PETTINGILL RICHARD R |
19,108 | $0.00 |
DA VILA ELIZABETH H |
19,108 | $0.00 |
WINGER DENNIS L |
19,108 | $0.00 |
LEVINE JOSHUA H |
200,000 | $0.00 |
LONDY KELLY J |
2,600 | $6.12 |
GOLDSTEIN JACK |
11,900 | $6.37 |
DADONE THERESA L |
17,400 | $0.00 |
MILLIKEN DARREN J |
22,400 | $0.00 |
RAANES CHRIS A |
39,800 | $0.00 |
LONDY KELLY J |
23,300 | $0.00 |
BERTOCCI DEREK A |
31,600 | $0.00 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
